Business
NeuroOne(R) Announces Initial Successful Cases Completed With OneRF(R) Trigeminal Nerve Ablation System at the University Hospitals in Cleveland
Patients Reported Pain Relief Without Postoperative Complications Further Validates NeuroOne's Patented Platform Technology for Both Brain Ablation and Pain Management Procedures EDEN PRAIRIE, MINN. - December 9, 2025 (NEWMEDIAWIRE) - NeuroOne Medic...
About this update from Neuroone Medical Technologies Corporation
[{"type":"image","caption":"","headline":"NeuroOne(R) to Report First Quarter Fiscal Year 2026 Financial Results on Tuesday, February 17 at 8:30 a.m. Eastern Time","size":{"original":{"width":140,"height":70,"url":"https://media.zenfs.com/en/newsmediawire_165/6e29368af07e7c003454bc6560423ba4"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/61CM7UIIJoR34ZjwWwyL7g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIxMDtoPTEwNTtjZj13ZWJw/https://media.zenfs.com/en/newsmediawire_165/6e29368af07e7c003454bc6560423ba4","width":140,"height":70}}},{"type":"text","content":"Patients Reported Pain Relief Without Postoperative Complications ","length":65,"tagName":"p"},{"type":"text","content":"Further Validates NeuroOne's Patented Platform Technology for Both Brain Ablation and Pain Management Procedures","length":116,"tagName":"p"},{"type":"text","content":"EDEN PRAIRIE, MINN. - December 9, 2025 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, has successfully used its OneRF(R) Trigeminal Nerve Ablation System to treat two patients with facial pain suffering from trigeminal neuralgia at the University Hospitals in Cleveland, Ohio.","length":491,"tagName":"p"},{"type":"text","content":"In August 2025, the Company received 510(k) clearance from the U.S. Food and Drug Administration ("FDA") to market its OneRF(R) Trigeminal Nerve Ablation System, which leverages the Company's proprietary OneRF(R) Ablation platform technology for the treatment of trigeminal neuralgia, a chronic pain condition affecting approximately 150,000 people in the United States annually(1). The trigeminal nerve is the main sensory nerve in the face associated with triggering excruciating pain for this condition.","length":520,"tagName":"p"},{"type":"text","content":"Dr. Michael Staudt, the Lincoln Endowed Chair in Brain Health and an Associate Professor of Neurological Surgery at University Hospitals, performed radiofrequency ("RF") ablations on two patients suffering from trigeminal neuralgia. The ablations were performed in the operating room and both patients reported pain relief, without complications. With NeuroOne's multi-contact probe, the surgeon was able to ablate...